Cowen & Co. analyst Shaul Eyal reiterated a Buy rating on Zscaler (ZS – Research Report) today and set a price target of $195.00. The company’s shares closed last Thursday at $142.13, close to its 52-week low of $125.12.
According to TipRanks.com, Eyal is a top 25 analyst with an average return of 28.0% and a 69.3% success rate. Eyal covers the Technology sector, focusing on stocks such as Evolv Technologies Holdings, CrowdStrike Holdings, and Palo Alto Networks.
Zscaler has an analyst consensus of Strong Buy, with a price target consensus of $233.31, which is a 78.7% upside from current levels. In a report issued on May 23, RBC Capital also maintained a Buy rating on the stock with a $200.00 price target.
Zscaler’s market cap is currently $20.05B and has a P/E ratio of -59.64.
Based on the recent corporate insider activity of 81 insiders, corporate insider sentiment is negative on the stock. This means that over the past quarter there has been an increase of insiders selling their shares of ZS in relation to earlier this year.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Zscaler, Inc., formerly known as SafeChannel Inc., is a cloud-based security solutions provider. The company offers a full range of enterprise network security solutions including internet security, web security, vulnerability management, firewalls, antivirus, and control over user activity in mobile, cloud computing, and Internet of Things environments.
Read More on ZS:
- H.C. Wainwright Sticks to Their Buy Rating for Adicet Bio (ACET)
- H.C. Wainwright Reiterates a Buy Rating on Co-Diagnostics (CODX)
- H.C. Wainwright Thinks OpGen’s Stock is Going to Recover
- H.C. Wainwright Sticks to Its Buy Rating for Safe Bulkers (SB)
- Analysts Conflicted on These Healthcare Names: Meridian Bioscience (VIVO), Puma Biotechnology (PBYI) and Roche Holding AG (OtherRHHVF)